Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2014 16:10 ET | Source: Lisata Therapeutics

NeoStem Announces Closing of Acquisition of California Stem Cell, Inc. and First Quarter 2014 Financial Results

NEW YORK, May 8, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced first quarter 2014 financial...
May 08, 2014 15:04 ET | Source: Open Minds

Leveraging Next Generation EHR Technology To Increase Productivity & Improve Client Care: Integrity House & OPEN MINDS Executive Web Briefing

GETTYSBURG, Pa., May 8, 2014 (GLOBE NEWSWIRE) -- Improving the "value" of services is a critical strategic challenge for executive teams of behavioral health organizations. And one essential approach...
May 08, 2014 15:04 ET | Source: Coalition for Pulmonary Fibrosis (CPF)

Daughters Turn "Sad" Mother's Day into Day of Hope

ATLANTA, May 8, 2014 (GLOBE NEWSWIRE) -- Lesley Steinberg dreads Mother's Day. The day of flowers and candy for most of her friends' mothers has been difficult for her since losing her mom to an...
May 08, 2014 12:35 ET | Source: Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ): Resolutions from Sobi's AGM

Stockholm, Sweden, May 8, 2014 (GLOBE NEWSWIRE) -- The Swedish Orphan Biovitrum AB (publ) (Sobi) Annual General meeting (AGM) convened earlier today in Stockholm and voted in favour of the resolutions...
May 08, 2014 12:34 ET | Source: Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ): Annette Clancy joins Sobi's Board of Directors

Stockholm, Sweden, May 8, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) Annual General meeting (AGM) today elected Annette Clancy to Sobi's Board of Directors. Ms. Clancy has over...
May 08, 2014 12:20 ET | Source: Alcobra Ltd.

Alcobra Announces FDA Clearance of Protocol for Phase IIb Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome

TEL AVIV, Israel, May 8, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company primarily focused on the development and commercialization of its proprietary drug...
May 08, 2014 10:30 ET | Source: Nymox Pharmaceutical Corporation

Nymox Announces Completion of Second Pivotal Phase 3 NX-1207 Trial for BPH

HASBROUCK HEIGHTS, N.J., May 8, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today that the last enrolled patient has completed participation in the Company's...
May 08, 2014 10:04 ET | Source: Colon Cancer Alliance

Colon Cancer Alliance Receives 4-Star Charity Navigator Rating For Fourth Year

WASHINGTON, May 8, 2014 (GLOBE NEWSWIRE) -- The Colon Cancer Alliance has received Charity Navigator's coveted 4-star rating for the fourth year in a row. The 4-star rating, Charity Navigator's...
May 08, 2014 09:08 ET | Source: Prophecy Health

Prophecy Healthcare, Inc.(R) Sponsors Local Rotary Club in Helping Stop Hunger

GREENSBORO, N.C., May 8, 2014 (GLOBE NEWSWIRE) -- Prophecy Healthcare Inc. has become a corporate sponsor for the local Rotary Club of the Triad's 5K and Fun Run being held around the campus of River...
May 08, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics' Data on Lead Candidate NS2 to be Presented at Society for Investigative Dermatology 2014 Annual Meeting

BURLINGTON, Mass., May 8, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...